Live feed
Filing
SC 13D
SC 13D0001104659-24-102046·Enavate Sciences GP, LLC
Schedule 13D ownership disclosure
Bicara Therapeutics Inc
Security class unavailable · CUSIP: 055477103
Event date: 2024-09-16
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,761,359
- Percent of class
- 9.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-102046
- Form type
- SC 13D
- Filer
- Enavate Sciences GP, LLC
- CIK
- CIK 1953107
- Filed
- Sep 23, 2024
- Reporting period
- Sep 16, 2024
- Description
- Schedule 13D beneficial ownership